Generate a tailored SOP for Dr. Brian Robertson. Improve your application with a focused, well-structured draft.
Mycobacterium tuberculosis are successful pathogens affecting humankind: 9 million people develop tuberculosis each year, resulting in 1.4 million deaths. A significant number of individuals mount an immune response sufficient to control the initial infection but remain susceptible to reinfection and reactivation of the disease over their lifetime. Immunological evidence suggests that a billion people worldwide harbour latent tuberculosis, with a ten percent lifetime risk of developing active disease. The development of improved drugs, diagnostics, and vaccines is central to the End-TB strategy, which aims for a 95% reduction in TB deaths by 2035 compared to 2015 and a 90% reduction in TB incidence rate by the same year. Additionally, the goal is to ensure that no TB-affected families face catastrophic costs due to the disease.
Specialisms available in Materials for the Energy Transition or Theory and Simulation of Materials.